CLINICAL_TRIALS
trial_result
· 2022-04-07
Clinical Trial Update: Phase 3 Extension Study of Dexpramipexole in ALS [Phase 3]
Summary
Phase 3 extension study update for dexpramipexole in ALS; study terminated with results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Knopp Biosciences | Conditions: Amyotrophic Lateral Sclerosis | Phase 3 | Status: TERMINATED | Results posted: 2022-04-07